Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Oxford Gene Technology OGT A Sysmex Group Company has launched a transformative nextgeneration sequencing NGS panel for constitutional cytogenetics research The CytoSure Constitutional NGS Panel contains the most uptodate handcurated content for inte...
Vetter a global operating Contract Development and Manufacturing Organization CDMO has brought together its development laboratories in one Ravensburg site end of last year Designed to improve workflow and enhance customer benefits within the daily s...
Pulmatrix Inc announced that the US Food and Drug Administration FDA has granted Fast Track designation to PUR Pulmazole the Companys inhaled itraconazole antifungal candidate being developed to treat allergic bronchopulmonary aspergillosis ABPA in p...
Compugen Ltd a clinicalstage cancer immunotherapy company and leader in predictive target discovery announced today that The European Patent Office EPO has granted the Company a new patent for the use of any antiPVRIG antibody in the treatment of can...
Predictive Technology Group and Atrin Pharmaceuticals LLC are entering into a collaboration agreement to develop molecular diagnostic tools to facilitate improved selection of cancer patients who would most benefit from treatment with DNA Damage and...
SAGA Diagnostics AB a cancer liquid biopsy and genomic testing company focused on precision oncology and noninvasive ultrasensitive monitoring of cancer patients today announces it has entered service agreements with the international pharmaceutical...
Ningbo NewBay Medical Technology Co Ltd a subsidiary of Ningbo Tai Kang Medical Technology Co Ltd announced today that it has entered into a licensing agreement with Genentech a member of the Roche Group under which it has been granted the exclusive...
Merck known as MSD outside the United States and Canada today announced the US Food and Drug Administration FDA has approved a New Drug Application NDA for DIFICID fidaxomicin for oral suspension and a supplemental New Drug Application sNDA for DIFIC...
Sirnaomics Inc Sirnaomics a leading biopharmaceutical company in discovery and development of novel RNAi therapeutics announced today that it has mobilized its research teams both in USA and China to develop novel RNAibased prophylactics and therapeu...
Neuraxpharm Group Neuraxpharm a leading European specialty pharmaceutical company focused on central nervous system CNS disorders today announces the expansion of its operations in Central Europe with the launch of Neuraxpharm Austria and the acquisi...
